Hill Democrats Continue Inquiries Into High Prices For New Versions Of Old Drugs; Avanir's Nuedexta And URL Pharma's Colcrys Targeted
Letters from Sen. Kohl and Reps. Waxman, Pallone and DeGette are reminiscent of the recent uproar over pricing for KV's Makena.